These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33253350)

  • 1. Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine.
    Hassan R; Allali I; Agamah FE; Elsheikh SSM; Thomford NE; Dandara C; Chimusa ER
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33253350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacomicrobiomics: a novel route towards personalized medicine?
    Doestzada M; Vila AV; Zhernakova A; Koonen DPY; Weersma RK; Touw DJ; Kuipers F; Wijmenga C; Fu J
    Protein Cell; 2018 May; 9(5):432-445. PubMed ID: 29705929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
    Sharma A; Buschmann MM; Gilbert JA
    Clin Pharmacol Ther; 2019 Aug; 106(2):317-328. PubMed ID: 30937887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
    Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery.
    Kamath S; Stringer AM; Prestidge CA; Joyce P
    Expert Opin Drug Deliv; 2023; 20(10):1315-1331. PubMed ID: 37405390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-microbiota interactions: an emerging priority for precision medicine.
    Zhao Q; Chen Y; Huang W; Zhou H; Zhang W
    Signal Transduct Target Ther; 2023 Oct; 8(1):386. PubMed ID: 37806986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.
    ElRakaiby M; Dutilh BE; Rizkallah MR; Boleij A; Cole JN; Aziz RK
    OMICS; 2014 Jul; 18(7):402-14. PubMed ID: 24785449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacomicrobiomics-Guided Precision Oncology: A New Frontier of P4 (Predictive, Personalized, Preventive, and Participatory) Medicine and Microbiome-Based Therapeutics.
    Arga KY; Attia H; Aziz RK
    OMICS; 2024 Jan; 28(1):5-7. PubMed ID: 38190279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Review: Pharmacogenomics and Personalized Medicine Customizing Drug Therapy Based on Individual Genetics Profiles.
    Dash B; Shireen M; Pushpendra ; Kumar S; Goel A; Semwal P; Rani R
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2024 Jul; 40():e20240011. PubMed ID: 38979579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.
    Jia L; Huang S; Sun B; Shang Y; Zhu C
    Front Endocrinol (Lausanne); 2023; 14():1149256. PubMed ID: 37033254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters].
    Zhou Q; Yu LS; Zeng S
    Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics: Driving Personalized Medicine.
    Sadee W; Wang D; Hartmann K; Toland AE
    Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics and individualized medicine: translating science into practice.
    Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
    Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes.
    Lam KN; Alexander M; Turnbaugh PJ
    Cell Host Microbe; 2019 Jul; 26(1):22-34. PubMed ID: 31295421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics: the promise of personalized medicine.
    Mancinelli L; Cronin M; Sadée W
    AAPS PharmSci; 2000; 2(1):E4. PubMed ID: 11741220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics for personalized pain medicine.
    Ko TM; Wong CS; Wu JY; Chen YT
    Acta Anaesthesiol Taiwan; 2016 Mar; 54(1):24-30. PubMed ID: 26976339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in Critical Care.
    Cheek D; Howington L
    AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM).
    Luo JQ; Shu Y; Zhang W
    Front Endocrinol (Lausanne); 2023; 14():1287807. PubMed ID: 37795358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.